Quantum X Labs Inc. QXL
5.00
(0.17)
(3.29%)
as of 25 Sep
- Market cap
- $111.8M
- P/E
- 34.2×
Follow QXL
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
38.93 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
61.90 | 16.43 | 8.26 | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(76.71) | (37.89) | (59.47) | (16.19) | |
P/B ratio |
3.16 | 1.06 | 2.60 | 6.32 | |
Price to Tangible BV |
29.48 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
61.46 | 16.76 | 9.19 | (2.53) | |
EV/EBITDA |
48.38 | 0.00 | 0.00 | 11.00 | |
EV/Operating CF |
(19.51) | (6.55) | (5.21) | (12.10) | |
EV/FCF |
(18.64) | (6.52) | (5.18) | (12.04) | |
Quick Ratio |
0.77 | 0.59 | 0.33 | 0.43 | |
Current Ratio |
0.86 | 0.68 | 0.41 | 0.48 | |
Net Debt/EBITDA |
(0.22) | (1.43) | (0.33) | 0.37 | |
Debt/Assets |
6.11% | 8.32% | 23.18% | 22.22% | |
Debt/Equity |
0.07 | 0.11 | 0.50 | 0.65 | |
Asset Turnover |
0.05 | 0.05 | 0.10 | (0.63) | |
Operating CF/Net income |
(0.43) | 1.00 | 0.39 | 0.67 | |
Capex/Depreciation |
(0.82) | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
63.14% | 0.00% | 4.01% | 4.23% | |
Selling, General and Administrative Expense of Revenue |
355.29% | 148.73% | (6.25%) | 29.15% | |
Intangible Assets out of Total Assets |
0.74 | 0.87 | 0.78 | 0.75 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.15% | 0.11% | |
Graham Net Nets |
(0.02) | (0.14) | (0.32) | (0.19) | |
Graham Number |
2.44 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
2.57% | (82.09%) | (147.95%) | (89.78%) | |
Free Cash Flow Yield |
(5.33%) | (15.64%) | (21.47%) | (8.62%) | |
Revenue per Share |
0.02 | 0.03 | (0.24) | 0.26 | |
Operating CF per Share |
(0.07) | (0.05) | (0.03) | (0.22) | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.09) | (0.05) | (0.03) | (0.22) | |
Cash per Share |
0.17 | 0.16 | 0.12 | 0.23 | |
Shareholders Equity per Share |
1.80 | 1.89 | 0.59 | 0.55 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.80 | 1.89 | 0.59 | 0.55 | |
Free Cash Flow |
(1.25) | (0.60) | (0.22) | (2.26) | |
Working Capital |
(0.55) | (1.35) | (2.41) | (4.45) | |
Capital Expenditures |
(0.19) | — | — | — | |
Net Current Asset Value |
(1.89) | (3.13) | (4.12) | (6.98) | |
EV/EBIT |
103.70 | 0.00 | 0.00 | 20.57 | |
Capex to Sales |
0.63 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
848.12% | (171.39%) | 27.65% | (124.88%) | |
Price to Operating Income |
104.44 | 0.00 | 0.00 | 19.82 | |
| Other line items | |||||
Average Receivables |
0.83 | 0.86 | 0.44 | 3.71 | |
Average Payables |
3.34 | 3.03 | 1.82 | 7.35 | |
Average Assets |
25.63 | 27.06 | 16.36 | 23.84 | |
Average Common Equity |
15.55 | 15.26 | 6.25 | 8.68 |
Columns are period end dates